PW Medtech Group Limited (HKG:1358)
Hong Kong · Delayed Price · Currency is HKD 1.010
-0.020 (-1.94%)
Jul 31, 2026, 3:58 PM HKT
PW Medtech Group Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 823.51 | 823.51 | 768.9 | 675.08 | 536.83 | 271.4 |
Revenue Growth | -2.53% | 7.10% | 13.90% | 25.75% | 97.80% | 9.72% |
Gross Profit Gross Profit Growth | 407.46 | 407.46 | 419.45 | 380.9 | 298.83 | 166.06 |
Operating Income Operating Income Growth | 125.71 | 125.71 | 173.65 | 179.14 | 98.17 | 47.07 |
Net Income Net Income Growth | 94.37 | 94.37 | 150.78 | 153.18 | 106.04 | 739.12 |
Earnings Per Share EPS Growth | 0.06 | 0.06 | 0.10 | 0.10 | 0.07 | 0.47 |
EPS Growth | -35.88% | -36.06% | -0.11% | 44.46% | -85.63% | 16.99% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Infusion Set Infusion Set Growth | 207.64 | 207.64 | 286.65 | 286.65 | 248.49 | 271.4 |
Blood Purification Blood Purification Growth | 611.79 | 611.79 | 482.26 | 482.26 | 288.34 | - |
Regenerative Medical Biomaterials Regenerative Medical Biomaterials Growth | 4.07 | 4.07 | - | - | - | - |
Total Total Growth | 823.51 | 823.51 | 768.9 | 768.9 | 536.83 | 271.4 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 1,808 | 1,808 | 1,687 | 1,595 | 1,388 | 2,412 |
Total Debt Total Debt Growth | 22 | 22 | 12.07 | 1.13 | 4.24 | 2.44 |
Net Cash (Debt) Net Cash Growth | 1,786 | 1,786 | 1,675 | 1,593 | 1,383 | 2,409 |
Net Cash Growth | 1.57% | 6.61% | 5.12% | 15.19% | -42.59% | 44.16% |
Net Cash Per Share Net Cash Per Share Growth | 1.18 | 1.18 | 1.09 | 1.02 | 0.88 | 1.54 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 240.7 | 240.7 | 318.43 | 211.03 | 269.23 | 37.24 |
Capital Expenditures CapEx Growth | -90.05 | -90.05 | -56.5 | -47.31 | -52.46 | -11.32 |
Free Cash Flow Free Cash Flow Growth | 150.66 | 150.66 | 261.93 | 163.73 | 216.77 | 25.92 |
Free Cash Flow Growth | -25.78% | -42.48% | 59.98% | -24.47% | 736.25% | -63.14% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 49.48% | 49.48% | 54.55% | 56.42% | 55.66% | 61.19% |
Operating Margin | 15.27% | 15.27% | 22.58% | 26.54% | 18.29% | 17.34% |
Pretax Margin | 20.04% | 20.04% | 29.88% | 34.23% | 29.39% | 271.73% |
Profit Margin | 11.46% | 11.46% | 19.61% | 22.69% | 19.75% | 272.34% |
FCF Margin | 18.30% | 18.30% | 34.06% | 24.25% | 40.38% | 9.55% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
| Period Ending | Aug '26 Aug 1, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
Dividend Per Share Dividend Per Share Growth | 0.064 | 0.058 | 0.092 | 0.089 |
Dividend Per Share Growth | -34.69% | -37.55% | 3.00% | - |
Dividend Yield | 6.34% | 5.05% | 10.72% | 14.38% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 1, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 14.53 | 18.08 | 9.27 | 7.61 | 8.23 | 1.73 |
Forward PE | - | 4.64 | 4.64 | 4.64 | 4.64 | 4.64 |
P/FCF Ratio | 8.64 | 11.32 | 5.33 | 7.12 | 4.03 | 49.32 |
PS Ratio | 1.58 | 2.07 | 1.82 | 1.73 | 1.63 | 4.71 |